About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05244356

Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation

This is a randomised controlled experiment in the form of a web based survey study which randomly exposes participants to different forms of public health messages, after which participants will be as...

Lead sponsor: Clinical Research Centre, Malaysia•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Clinical Research Centre, Malaysia

Collaborators

Institute for Health Behavioral Research, Malaysia
University of Malaya
UNICEF Malaysia
Ministry of Health, Malaysia
London School of Economics and Political Science

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Willing and able to give informed consent for participation in the trial
•Malaysian nationality.
•Can understand either the English or Malay language.
•Aged 18 years or above

Exclusion Criteria

•Received at least one COVID-19 vaccination dose

Related studies

Positioning of Children With Acute Respiratory Insufficiency

NCT07170085 · Acute Respiratory Disease

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

RECRUITINGPhase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

NCT05101213 · Adenovirus Infection, BK Virus Infection, and more

RECRUITINGPhase 1/2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

NCT04565665 · COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, and more

Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19

NCT06871293 · Long COVID-19 Syndrome, COVID 19, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 17, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment5,784

Start dateApr 2021

Last updatedFeb 17, 2022

Condition

COVID-19 Respiratory Disease Vaccine Refusal Infectious Disease Coronavirus Infections+5 more

Locations shown

Institute for Clinical Research, National Institutes of Health, Malaysia

Shah Alam, Selangor

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 17, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions